Heidi Fields - 06 Jun 2023 Form 4 Insider Report for Icosavax, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jun 2023, 16:41:16 UTC
Prior SEC filing
30 May 2023
Next SEC filing
20 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Heidi Fields

Key filing fact

Heidi Fields filed Form 4 for Icosavax, Inc. on 08 Jun 2023.

Key facts

  • This page summarizes Heidi Fields's Form 4 filing for Icosavax, Inc..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 08 Jun 2023, 16:41.

Change

  • Previous filing in this sequence was filed on 30 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICVX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+17,000
Change %
Price
$0.000000
Shares after
17,000
Date
06 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,000
Exercise price
$9.89
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12th of the total number of shares of common stock subject to the option vest monthly following June 6, 2023, the vesting commencement date, provided if the next occurring annual meeting of the Issuer's stockholders occurs prior to the full vesting of the option, any remaining options will vest on the date of such annual meeting, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .